Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA).

NCT03492658 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT03492658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03492658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA).
Lead sponsor
Leiden University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
May 17, 2018
Completion date
April 6, 2022
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatic diseases, rheumatoid arthritis